Testosterone
FDA Approved, EMA Approved
Contents
Description
Testosterone replacement therapy is used in individuals with hypogonadism and disorders of sexual development. In 46,XX disorder of gonadal development with virilization, testosterone may be used for masculinizing hormone therapy when appropriate. It promotes development and maintenance of male secondary sexual characteristics.
Indications & Therapeutic Use
hypogonadism, testosterone deficiency, disorders of sexual development, gender dysphoria
Global Availability (10 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Buy / Source Testosterone — GNH India
128 matching products available through GNH India. Select a product to view details and request a quote on the GNH India website.
Androgel
EU
Androtop
EU
Itnogen
EU
NATESTO
4.5 %gelCANADA
TARO-TESTOSTERONE GEL
1 %gelCANADA
Testarzon
EU
Testavan
EU
TESTIM 1%
1 %gelIRELAND
Products and ordering are fulfilled by GNH India. You will be redirected to www.gnhindia.com.
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
Testosterone
| Generic Name | testosterone |
| Brands | 1 brand available |
| Active Ingredient | testosterone |
| Drug Class | hypogonadism |
| Manufacturer | AbbVie |
| Dosage Forms | transdermal gel 1%, 1.62%; intramuscular injection; transdermal patch |
| Medical Code | G03BA03 |
| Orphan Status | No |
| Cold Chain | Not Required |
| Lead Time | 5 days |
| Reg. Status | FDA Approved, EMA Approved |
| Clinical Trial | NCT00114920 |
| Countries | 10 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations11 Validated Nodes